People in the News | GenomeWeb

People in the News

Premium

Alnylam Pharmaceuticals announced that CSO John Schmidt is leaving the company, less than a year after he joined the RNAi drugs shop.

Alnylam did not provide a reason for the departure. According to a company filing with the US Securities and Exchange Commission, Schmidt will officially step down on Sept. 30.


RXi Pharmaceuticals said that CFO and Executive Vice President of Business Operations Stephen DiPalma has resigned to pursue other opportunities.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.